Psychedelics are gaining popularity and legal traction in the United States, with a significant increase in users despite pushback from conservative groups. A recent study by the Rand Corporation revealed that millions of adults have tried various psychedelics, with psilocybin mushrooms being the most commonly used. This shift mirrors the earlier acceptance of cannabis, suggesting a broader cultural and legislative movement towards the decriminalization of psychedelics.

According to the survey, about 11 million adults, or 4.26% of the relevant age group, reported using psilocybin in the preceding year. The research, conducted in September 2025, also highlighted the use of other psychedelics like MDMA, Amanita muscaria, ketamine, LSD, and DMT, indicating a diverse landscape of psychedelic consumption. This increasing acceptance and use of psychedelics may have significant implications for mental health treatment and drug policy reform in the country.

Moreover, the growing trend of microdosing, where individuals consume sub-threshold amounts of psychedelics, underscores a shift in perception towards these substances. The findings reveal not only a growing interest but also a potential pathway for therapeutic application, highlighting the need for continued research and a re-evaluation of regulatory frameworks surrounding psychedelics in the United States.